For instance, EGFR mediated the efficacy of CAP in killing EGFR-overexpressing oral squamous cell carcinoma cells [132] and the expression of death receptors such as TNFR1 and DR4/5 were noticeably enhanced in glioblastoma cells after CAP treatment [133]. The gene discussed is EGFR; the disease is oral cavity squamous cell carcinoma.